Previous 10 | Next 10 |
RAPT Therapeutics (NASDAQ: RAPT) , a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases, has closed its previously ann...
SOUTH SAN FRANCISCO, Calif., Aug. 11, 2021 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet n...
MediciNova (MNOV) +52% on positive MN-166 data.Raven Industries (RAVN) +50% on being acquired by CNHI for $58.0 per share.Torchlight Energy Resources (TRCH) +39% after update on proposed business combination timing and date for preferred dividend.Hennessy Capital Investment Cor...
SOUTH SAN FRANCISCO, Calif., June 18, 2021 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet n...
RAPT Therapeutics (RAPT) has priced its public offering of ~3.8M common shares at $33.00/share. for expected gross proceeds of ~$125M.Underwriters' over-allotment is an additional 568,181 shares.Closing date is June 18. J.P. Morgan, SVB Leerink and Piper Sandler are acting as joint lead book-...
SOUTH SAN FRANCISCO, Calif., June 15, 2021 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet n...
Are These The Best Health Care Stocks To Buy Right Now? While retail traders digest news about rising inflation and the latest meme stocks, health care stocks remain viable plays. For one thing, the health care industry remains one of, if not, the most crucial sectors of busines...
RAPT Therapeutics (RAPT) announces that it has commenced an underwritten public offering of $125M of shares.Expects the underwriters to be granted a 30-day option to purchase up to an additional $18.75M of shares.Shares down nearly 3% after market. For further details see: ...
SOUTH SAN FRANCISCO, Calif., June 14, 2021 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet n...
RAPT Therapeutics (NASDAQ: RAPT) stock was crushing it on Monday, with shares skyrocketing 110.4% as of 11:59 a.m. EDT. The huge gain came after the company announced positive top-line results from a phase 1b clinical study evaluating RPT193 in treating moderate-to-severe atopic der...
News, Short Squeeze, Breakout and More Instantly...
RAPT Therapeutics Inc. Company Name:
RAPT Stock Symbol:
NASDAQ Market:
RAPT Therapeutics Inc. Website:
SOUTH SAN FRANCISCO, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based therapeutics company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflamm...
SOUTH SAN FRANCISCO, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based therapeutics company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflamm...
2024-02-23 01:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...